MedPath

SANDOZ PIRFENIDONE TABLETS

SANDOZ PIRFENIDONE TABLETS

Approved
DIN Number

02488515

Drug Class

Human

Market Date

May 4, 2021

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02488515
AIG Number0153328003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX05 PIRFENIDONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification48:02.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PIRFENIDONEActive
Strength: 801 MG
Monograph: PIRFENIDONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.